High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$49K
$49,085
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
MCRB
S
Seres Therapeutics, Inc.
DesRosier Thomas
• Officer • See Remarks
10b5-1 Sell
2026-02-15
$661
|
||||||
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-15 | $661 | S | Form 4 |
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-15 | $754 | S | Form 4 |
| MCRB |
Seres Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-02-15 | $2,194 | S | Form 4 |
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2026-02-15 | $635 | S | Form 4 |
|
MCRB
S
Seres Therapeutics, Inc.
DesRosier Thomas
• Officer • See Remarks
10b5-1 Sell
2025-11-15
$1,315
|
||||||
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 Sell
|
2025-11-15 | $1,315 | S | Form 4 |
|
MCRB
S
Seres Therapeutics, Inc.
Henn Matthew R
• Officer • See Remarks
10b5-1 SellΔOwn -14.3%
2025-11-15
$21,746
|
||||||
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -14.3%
|
2025-11-15 | $21,746 | S | Form 4 |
| MCRB |
Seres Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-15 | $3,754 | S | Form 4 |
|
MCRB
S
Seres Therapeutics, Inc.
Young Teresa L.
• Officer • See Remarks
10b5-1 SellΔOwn -11.0%
2025-11-15
$18,027
|
||||||
| MCRB |
Seres Therapeutics, Inc.
|
Officer • See Remarks
10b5-1 SellΔOwn -11.0%
|
2025-11-15 | $18,027 | S | Form 4 |